Capital Roundtable



Partial List of
Past Attendees

3i Corp.

Acacia Venture Partners

Acon Investments


Alston & Bird LLP

Altaris Capital Partners

Alumni Capital Network

Alvarez & Marsal

Antelum Capital Partners

Arcapita Inc.

Arsenal Capital Partners

Avondale Partners

Bank of Ireland

Barclays Capital Inc.

Beecken Petty O'Keefe

BioEnterprise Corp.

Cain Brothers & Co.

Camden Partners

CCMP Capital Advisors

Charter Oak Equity

Charterhouse Group Inc.

Choate Hall & Stewart

CRT Capital Holdings

Deloitte & Touche

Easton Associates

Enhanced Equity Fund

Ernst & Young

Fidelity Equity Partners

FirstLight Financial

Fletcher Spaght Inc.

Flexpoint Ford LLC

Galen Partners LP

Gardere Wynne Sewell

GE Healthcare Financial

General Atlantic

Genesis HealthCare

Gentium S.p.A.

Golden Gate Capital

Golub Capital LLC

Goodwin Procter LLP

Graham Partners Inc.

Great Point Partners

Greene Holcomb & Fisher

Halifax Group

Harris Williams & Co.

Health Enterprise Partners LLC

Howard Burde Health Law LLC

International Finance

Internet Capital Group

IQuum Inc.

Irving Levin Associates

Ivy Capital Partners

Kohlberg Kravis & Roberts & Co.

Korn/Ferry International

Lazard Middle Market

Leerink Swann & Co.

Liberty Partners LP

Linden Capital Partners

Longitude Capital Management Co.

Madison Capital Funding

Marwood Group

MidCap Financial LLC

Millbrook Management

Morgan Joseph & Co.

MTS Health Partners LP

Nautic Partners

Needham & Co.

NGN Capital LLC

Novacap Investments

Oak Hill Capital Partners

Ontario Teachers' Pension Plan

Parthenon Group

Pepper Hamilton LLP

Pomona Capital LP

PrimaMed Physicians Association

Private Advisors LLC

Proskauer Rose LLP

Psilos Group Partners

Raven Pacific Group

Ross & Co. Inc.

SAC Capital

Sheppard Mullin Richter & Hampton LLP

Siemans Financial

Silver Point Capital LP

Solera Capital LLC

Stephens Group LLC

Summit Partners LP

Talcott Partners


TowerBrook Capital Partners LP

Triad Healthcare Inc.

Triple Tree LLC


Vestar Capital Partners

Volante Capital LLC

Wells Fargo Foothill Inc.

Welsh Carson Anderson & Stowe LP

Association Partners


Research Partners

Media Partners


The Deal


Capital IQ


Clear the date October 21 on your calendar!

CLICK HERE now to register before it's too late!

An All-NEW MasterClass™

On Private Equity & Mezz Investing

In Middle-Market Healthcare Companies


New Sectors, New Structures, New Opportunities

For Private Equity Investing in Healthcare,

Now That the Government’s Reforms

Have Tilted the Playing Field

Attendance Is Limited!

  CLICK HERE to Register Now



Christopher W. Kersey, M.D., M.B.A.

Managing Member

Camden Partners Holdings LLC

Featuring Keynote Speech by

Fred L. Brown

Former Chairman of The Joint Commission

CEO, Fred L. Brown & Associates


Featuring 20 Expert Speakers

  • Kimon Angelides, EosHealth
  • Todd C. Cozzens, Picis Inc.
  • Richard R. D'Antoni, D'Antoni Partners Inc.
  • James A. Datin, Safeguard Scientifics Inc.
  • Anthony B. Davis, Linden LLC
  • Raymond G. Falci, Cain Brothers & Co. LLC
  • Lee S. Feldman, Choate Hall & Stewart LLP
  • Brian D. Fortune, Marwood Group LLC
  • Faraaz Kamran, Madison Capital Funding LLC
  • Stephen M. Krupa, Psilos Group Managers LLC
  • Jerry Larson, Argo Inc.
  • Dan Mendelson, Avalere Health LLC
  • Mark Pacala, Oak Hill Capital Management LLC
  • Gregory Park, RBC Capital Markets Corp.
  • Jonathan R. Phillips, Healthcare Growth Partners LLC
  • Anil Shrivastava, Vestar Capital Partners Inc.
  • Ryan T. Stewart, Triple Tree LLC
  • W. Paul Wallace, SV Life Sciences


Click Here to Register >>   Purchase Audio Package >>

 Visit Audio Library >>    Add to Outlook Calendar >>



Thursday, October 21, 2010

8:00 am – 5:00 pm
New York City 

Designed to Meet the Needs of GPs, LPs, & Managers of Buyout, Growth Equity, Mezzanine, & Lending Funds, as Well as Independent Sponsors, Operating Partners, Portfolio Company Managers, and the Bankers, Lawyers, Accountants, &Other Advisors Who Support Them

Faculty | Schedule | Registration | Location | Sponsorship | Audio Package |

With more than 30 million new insureds about to receive healthcare coverage, more and more IPOs in the pipeline, and health and wellness opportunities grabbing more and more of the headlines each month, it’s no wonder that private equity investors are increasingly attracted to healthcare companies.


Consider this -- thanks to the recently enacted healthcare reforms, the government is going to be spending billions of dollars on new initiatives in the coming months and years, starting off with $26 billion alone allocated at the start of August. Healthcare already generates approximately $23 trillion in revenue annually -- 17% of U.S. GDP -- and is expected to grow to more than $27 trillion by the end of this decade.


Where are these dollars going? For care and medicine for the elderly. For pediatric and rehabilitation medicine. For behavioral and mental health issues. For sophisticated IT services to improve compliance, safety, and outcomes.


And that’s just for starters. Healthcare is now considered an entitlement expected to offer the government and other payers a visible and rapid ROI -- and the entitlement pie is anticipated to continue expanding in the coming decades.


What’s more, while prices in most other sectors of the economy are being slashed as products commoditize, competition intensifies, and consumers pull back on discretionary spending, healthcare remains relatively unaffected. Users of healthcare are willing to pay for superior outcomes and a greater quality of life, so growth rates in healthcare spending will likely continue to exceed those of most other vertical industries.


Now is the time to act, and this conference is the place to start. To grasp the opportunities in private equity investing in middle-market healthcare companies in 2011 and 2012, please don’t miss The Capital Roundtable’s full-day conference --


New Sectors, New Structures, New Opportunities

For Private Equity Investing in Healthcare,

Now That the Government’s Reforms

Have Tilted the Playing Field


This all-new conference on Thursday, October 21, in New York City expands the content of our previous conference in April. We’ll identify and dissect the business models that are best positioned to blossom in the months ahead.


These include companies able to deliver superior access (dialysis centers, concierge medicine, clinical laboratories, acute care hospitals and ambulatory surgicenters), back-office companies able to maximize revenue capture while providing billing, compliance, safety, and other services, and IT services that not only lower costs but also improve outcomes through data mining.


We’ll also help you better manage your current portfolio companies as the industry shifts from acquisitive growth to organic growth. You’ll hear how other firms are driving growth and raising valuations, maximizing performance in the new reimbursement environment.


While this should be all the reason you need to confirm your attendance right now, The Capital Roundtable always believes in rewarding first responders. So when you sign up now for this conference, you’ll receive our special Early Bird Discount -- a generous savings of $400!


One Day That Can Sparkplug Your Entire Year.


The information we’ll provide in this all-new conference is up-to-the-minute… and remarkably candid. You will hear the latest word on what i’s are being dotted and t’s being crossed in Washington, and what current acquisitions, alliances, and deals are taking place.


And as our chair, we are privileged to have the expertise of Christopher W. Kersey of Camden Partners Holdings LLC. Camden Partners is one of the country’s largest growth equity and investment management funds with more than $700 million under management.


Christopher currently serves on the boards of LipoScience, MinSec Holdings, and PatientSafe Solutions. He also serves as a board trustee of both Johns Hopkins Medicine and the Johns Hopkins Hospital.


Some of Dr. Kersey’s previous portfolio companies include MedServe Inc. (acquired by Stericycle Corp., NASDAQ: SRCL), AlgoRx Pharmaceuticals Inc. (acquired by Anesiva Corp., NASDAQ: ANSV), ComView Medical Systems (acquired by ElectroMed Corp.), Pet DRx Corp. (acquired by VCA Antech Inc., NASDAQ: WOOF), Targacept Corp. (NASDAQ: TRGT) and Xeotron Corp. (acquired by Life Technologies Corp., NASDAQ: LIFE).


Christopher received a BA from Stanford University, an MBA from Harvard Business School, and an MD from Emory University School of Medicine.


We’ve Called in 20 Top Specialists to Advise and Consult.


Along with Christopher, you’ll hear from 20 noted private equity healthcare experts, including GPs, portfolio company operating executives, investment bankers, lenders, consultants, and more. All masters of the healthcare marketplace, they will share their successes -- and missteps -- in four revealing panel discussions.


Register now to find out the answers to topical questions like these --


  • What are the known certainties affecting healthcare now that reform has passed?
  • Which sectors are most attractive to investors right now, and which may make investors nervous?
  • Can physicians reassert themselves to take command of healthcare’s new directions?
  • Which areas have the greatest potential for outsourced solutions by hospitals and other providers?
  • What new innovations will the re-regulation era encourage that close the gap between physicians and patients?
  • What metrics should you use when assessing a healthcare deal today?
  • How are lenders approaching healthcare deal financing? What structures are most common?
  • What are the keys to successful healthcare exits? What are realistic time frames for current deals?
  • How will the trend of hospital and healthcare IT company consolidation affect future PE investing?
  • And much, much more.


Dr. Kersey Can See You on October 21 if You Respond Today.


Like any appointment schedule, we only have so many spaces for attendees at this conference, and we eventually have to turn people away. So we encourage you to make your plans now and ensure yourself a seat.


You will also ensure yourself excellent networking opportunities. We’ve built in plenty of time where you can connect with fellow attendees and featured speakers, including session breaks and an open lunch. You’ll leave this conference with contacts, conclusions and confidence -- everything you need to make your mark the very next day.


You should attend this conference if you are a --


  • GP or LP looking to invest in healthcare companies.
  • Operating partner or operating executive of a healthcare portfolio company.
  • Lender wishing to participate in healthcare transactions.
  • Hedge fund manager or venture capitalist seeking investments in healthcare.
  • Investment banker pursuing deals within the healthcare industry.
  • Attorney or advisor who focuses on the healthcare space.
  • Executive search professional recruiting for the PE industry.

Remember, register with our Early Bird Discount by September 10, 2010, and you’ll save $400 off our standard fee! Please make your reservation now so you’re not disappointed. We’ll be looking forward to greeting you.


For more information, please feel free to contact Dana DeMattia at 212-832-7333 ext. 102 or


This conference is being produced by The Capital Roundtable, America’s leading conference organization focusing on “need-to-know” information for professionals in the middle-market private equity community. For more information about The Capital Roundtable’s 25 annual MasterClasses and other events and programs, please visit

The Capital Roundtable thanks Argo Inc. for sponsoring this outstanding event. It’s due in great part to their collaboration and support that we have the resources to make this event so worthwhile for you.

^ Back to Top ^


Chaired By

  • Christopher W. Kersey, M.D., M.B.A., Managing Member, Camden Partners Holdings LLC

Hosted By

  • Burt Alimansky, Managing Partner, Alimansky & Bethell Group, and Chairman, The Capital Roundtable


  • Kimon Angelides, Chief Executive Officer, EosHealth
  • Fred L. Brown, Chairman, Fred L. Brown & Associates
  • Todd C. Cozzens, Vice Chairman & CEO, Picis Inc.
  • Richard R. D'Antoni, Managing Partner, D'Antoni Partners Inc.
  • James A. Datin, E.V.P. & Managing Director, Safeguard Scientifics Inc.
  • Anthony B. Davis, Managing Partner, Linden LLC
  • Raymond G. Falci, Managing Director, Cain Brothers & Co. LLC

  • Lee S. Feldman, Partner, Choate Hall & Stewart LLP
  • Brian D. Fortune, Chief Political Strategist, Marwood Group LLC
  • Faraaz Kamran, Director, Madison Capital Funding LLC
  • Stephen M. Krupa, Managing Member, Psilos Group Managers LLC
  • Jerry Larson, U.S. Dir.--Healthcare Practice, Argo Inc.
  • Dan Mendelson, President, Avalere Health LLC

  • Mark Pacala, Senior Advisor, Oak Hill Capital Management LLC
  • Gregory Park, Managing Director, RBC Capital Markets Corp.
  • Jonathan R. Phillips, Managing Director, Healthcare Growth Partners LLC
  • Anil Shrivastava, Managing Director, Vestar Capital Partners Inc.
  • Ryan T. Stewart, Director, Triple Tree LLC
  • W. Paul Wallace, Venture Partner, SV Life Sciences

^ Back to Top ^


07:30 - 08:30

08:30 - 09:00

09:00 - 09:45

09:45 - 10:30
10:30 - 11:00
11:00 - 12:15

12:15 - 01:15
01:15 - 02:15

02:15 - 03:15

03:15 - 03:30
03:30 - 04:30



Thursday, October 21, 2010
Registration, Networking, & Continental Breakfast

Welcoming Remarks & Audience Introductions

Introductory Keynote -- "Managing Through the Transition of National Healthcare Reform

Chairman’s Keynote -- “Micro In-the-Trenches Perspective”

Coffee & Networking Break

First Panel -- “Getting the Jump on Healthcare Dealmaking in 2011 --

Sectors, Trends, & Structures PE Investors Should Focus On”

Networking Luncheon & Meet the Speakers

Second Panel -- “Managing the Impact of the Federal Healthcare Policy Shift -- The Legal & Regulatory Changes That Will Impact PE Investors Most”

Third Panel -- “Overseeing Healthcare Companies in Middle-Market PE Portfolios -- What Help They May Need to Adapt to the Reforms, and to Prepare for Exits or IPOs”

Coffee & Networking Break

Fourth Panel -- "Forecasting the Future of Healthcare IT --

Which Opportunities & Markets Are Likely to Be Most Sustainable  -- or Most Risky” 

Networking & Adjournment


^ Back to Top ^


  • Early Bird Registration Fee -- save $400 off the standard fee! Register by Friday, September 10, and the fee for the MasterClass is $995.
  • Premiere Registration Fee -- save $200 off the standard fee! Register by Friday, October 1, and the fee for the MasterClass is $1195.
  • After that, the standard fee is $1395 for the MasterClass.
  • At the door, if space is available, the fee is $1495 for the MasterClass.
  • Special group rates -- The Capital Roundtable offers a special discount for 2 or more people.  For more info, please contact Shaina Mardinly or 212-832-7333 ext 103.

Click Here to Register >>    Purchase Audio Package >>


 Visit Audio Library >>    Add to Outlook Calendar >>

You can pay by credit card (using the links above) or by check. Mail your check and business card to: New York Business Roundtable Inc., 12 East 44 Street, Penthouse, New York, NY 10017.

If the program is oversubscribed, we will notify you immediately and not charge your credit card.  (If you need to cancel, please do so by Thursday, October 14, at 5:00pm, and we will credit you for a future MasterClass.)

From time to time, for reasons beyond Capital Roundtable's control, program schedules and speakers become subject to change.  We make every effort to announce substantive changes by email to registrants at least 48 hours in advance.

Have a special question?  Please contact Shaina Mardinly at 212-832-7333 ext.103 or by email at

^ Back to Top ^


The University Club

Council Room -- Seventh Floor

One West 54 Street (at 5th Avenue)

New York City

^ Back to Top ^

Audio Package

Can't attend but want to hear the program? You can buy the audio package along with the handouts. Purchase the audio package online now.

^ Back to Top ^


The Capital Roundtable offers excellent marketing and business development opportunities to reach the middle-market private-equity community . For more details, please contact Dana DeMattia at 212-832-7333 or by email at

^ Back to Top ^